Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sab Biotherapeutics, Inc. (BCYP) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sab Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1833214.
Total stock buying since 2021: $12,688,038.
Total stock sales since 2021: $2,196.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 17,740 | $15,876 | 0 | $0 | 12,026,284 | $0 |
| 2021 | 1,267,100 | $12,672,162 | 278 | $2,196 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-12 | 1,740 | $1,531 | 0 | $0 | 0 | $0 |
| 2023-11 | 16,000 | $14,345 | 0 | $0 | 12,026,284 | $0 |
| 2021-10 | 15,500 | $156,162 | 278 | $2,196 | 0 | $0 |
| 2021-01 | 1,251,600 | $12,516,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-07 | Sullivan Eddie Joe (Chief Executive Officer) | Buy | 1,740 | .88 | 1,531 |
| 2023-11-30 | King Michael (CHIEF FINANCIAL OFFICER) | Buy | 5,000 | .90 | 4,500 |
| 2023-11-29 | Reich Samuel J (Executive Chairman) | Buy | 11,000 | .90 | 9,845 |
| 2023-11-24 | Ellias Helen K. | Option Ex | 2,857,142 | .00 | 0 |
| 2023-11-24 | Moin Andrew | Option Ex | 4,584,571 | .00 | 0 |
| 2023-11-24 | Petry John (Director) | Option Ex | 4,584,571 | .00 | 0 |
| 2021-10-26 | Beyer Russell P (Chief Financial Officer) | Sale | 278 | 7.90 | 2,196 |
| 2021-10-14 | Reich Samuel J (CEO and CFO) | Buy | 1,000 | 10.11 | 10,110 |
| 2021-10-13 | Katz Ilan | Buy | 500 | 10.11 | 5,052 |
| 2021-10-01 | Katz Ilan | Buy | 1,000 | 10.09 | 10,090 |
| 2021-10-01 | Spragens Jeffrey G | Buy | 13,000 | 10.07 | 130,910 |
| 2021-01-14 | Katz Ilan | Buy | 417,200 | 10.00 | 4,172,000 |
| 2021-01-14 | Big Cypress Holdings Llc (CEO and CFO) | Buy | 417,200 | 10.00 | 4,172,000 |
| 2021-01-14 | Reich Samuel J (CEO and CFO) | Buy | 417,200 | 10.00 | 4,172,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCYP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sab Biotherapeutics, Inc. (symbol BCYP, CIK number 1833214) see the Securities and Exchange Commission (SEC) website.